# Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children

> **NCT01217099** · NA · TERMINATED · sponsor: **Chongqing Medical University** · enrollment: 47 (actual)

## Conditions studied

- Refractory Mycoplasma Pneumoniae Pneumonia

## Interventions

- **DRUG:** methylprednisolone
- **DRUG:** azithromycin

## Key facts

- **NCT ID:** NCT01217099
- **Lead sponsor:** Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 47 (ACTUAL)
- **Why stopped:** terminated
- **Last updated:** 2010-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01217099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01217099, "Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01217099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*